Accelerating Breakthroughs in Drug Discovery

The Discovery Hub is where biology meets technology to redefine how new drugs are discovered. Focused on the earliest stages of the pipeline, this track explores how advances in genomics, proteomics, and computational biology are unlocking new therapeutic targets and accelerating R&D. From hypothesis generation to candidate selection, sessions will highlight how leading organisations are improving speed, accuracy, and success rates in discovery science.

What we think you'll be interested in...

Hear from pioneering scientists, academics and innovators who are redefining the frontiers of drug discovery, from academia to global pharma and emerging biotech.
Lei Xie
Professor
Northeastern University
Lei Xie
Sally Thompson-Iritani
Assistant Vice Provost
University of Washington
Sally Thompson-Iritani
Daya Shankar
Dean, School of Sciences & AI Faculty
Woxsen University
Daya Shankar
Jake Chen
Endowed Professor & Founding Director, SPARC
University of Alabama
Jake Chen
Srijit Seal
Visiting Researcher
Broad Institute of MIT and Harvard
Srijit Seal
Anu Sharma
Principal Scientist and Director, Center for Observational and Real-World Evidence (CORE)
Merck
Anu Sharma
Catherine Brownstein
Scientific Director, Manton Center for Orphan Disease Research
Harvard Medical School
Catherine Brownstein
Yi-Hsiang Hsu
Director & Associate Professor
Broad Institute of Harvard and MIT
Yi-Hsiang Hsu
Stephanie Oestreich
Managing Director
Myeloma Investment Fund
Stephanie Oestreich
Omer Alis
Director of Artificial Intelligence
Northeastern University
Omer Alis
Beauty Pandey
Associate Dean and Associate Professor
Woxsen University
Beauty Pandey

BioTechX USA is proud to announce its accreditation by The CPD Group , a globally recognised body for quality professional development. This milestone reflects our commitment to delivering educational experiences that foster professional growth and enhance expertise across the drug safety, pharmacovigilance, and risk management community.

What CPD Accreditation Means for Attendees

This accreditation underscores our dedication to providing valuable learning opportunities in drug safety and pharmacovigilance. Attendees can leverage this recognition to support their career progression and demonstrate their commitment to continuous professional improvement.

Benefits for Attendees

  • Collect CPD Credits – Earn trackable CPD credits that count toward annual professional development requirements.
  • Receive Personalised Certificates – Each seminar you attend earns a free personalised certificate recognising your commitment.
  • Engage with High-Quality Content – Access expert-led seminars, case studies, and panel discussions delivering the latest insights.

 

The Interactive Poster Session at BioTechX is a dynamic showcase of the latest research, clinical innovation, and emerging developments in biotech. Open to all attendees, this session offers an exciting opportunity to explore cutting-edge work from leading clinicians, researchers, and industry experts in a collaborative, engaging environment.

 

Why This Matters for Innovators

While the Poster Session is open to all attendees, it offers particular value for healthcare professionals by providing practical clinical insights that are directly relevant to patient care. You will benefit from real-world learning shared by frontline delivery teams who are implementing advanced therapies, and they will gain exposure to emerging techniques, trial outcomes, and new clinical evidence. This session also provides a unique opportunity to see how advanced therapies are translating into real-world practice, helping clinicians stay at the forefront of innovation and patient treatment pathways.

 

Value for Innovators

Innovative professionals attending the Poster Session will gain clinically relevant insights that support professional development, with exposure to innovations across the therapy pathway from trial design to patient delivery. They will also have the opportunity to benchmark practice against leading institutions and access research and findings before wider publication.

 

Networking & Collaboration

The Poster Session is not just about learning—it's also about connecting. You’ll be able to meet researchers, discuss research directly, and build relationships with senior clinical leaders and industry specialists, creating valuable collaboration and referral opportunities.

 

Submit a Poster or Just Attend

Whether you want to present your work or simply engage with leading research, the Poster Session welcomes you. You can submit a poster to showcase your findings, clinical case studies, or innovation projects, or attend as a delegate to learn, discuss, and connect with experts. The session also provides the opportunity to contribute to the conversation through questions, insights, and collaboration.

AI in Drug Discovery & Development

 

AI in Drug Discovery & Development

Modernizing Drug Development

Explore how AI is reshaping drug discovery from target identification through to optimisation, with a focus on multimodal data, predictive modelling, and model-informed development strategies.

Bioinformatics + InSilico R&D

Bioinformatics + InSilico R&D

Data-Driven Precision Therapeutics Through Computational Biology

Uncover how computational biology, multi-omics, and simulation are driving deeper biological insight and enabling more precise, data-led therapeutic development.

Large Language Models

Large language Models

Agentic AI Automating R&D, Extracting Knowledge, and Scaling Scientific Decision-Making

See how LLMs and agentic AI are being embedded across R&D to extract knowledge, automate workflows, and enhance scientific decision-making at scale.

The Value for DISCOVERY LEADERS

ADVANCING TARGET IDENTIFICATION

Explore cutting-edge approaches in genomics, proteomics, and multi-omics to uncover and validate novel drug targets. Learn how leading teams are improving confidence in early-stage discovery decisions.

ACCELERATING R&D PIPELINES

Discover how AI, automation, and high-throughput technologies are reducing timelines from hypothesis to candidate selection. Collaborate with biotech and pharma innovators to overcome bottlenecks in early discovery.

 

Get involved at BioTechX USA

 

 

TO SPONSOR


Jamie Blowfield

jamie.blowfield@terrapinn.com

 

Katie Duncan

katie.duncan@terrapinn.com

 

TO SPEAK


Anna Abiola
anna.abiola@terrapinn.com

 

MARKETING OPPORTUNITIES


Davide Russano

davide.russano@terrapinn.com